O. Rixe

Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Joseph A. Sparano, Eduard Vrdoljak, O. Rixe et al. · Journal of Clinical Oncology · 2010 · 219 citations · Full text

Medicine, Oncology, Pharmacology +10

Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma

Laurent Zelek, S. Barthier, M. Riofrio et al. · Cancer · 2001 · 157 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase I dose escalation (DE) and pharmacokinetics (PK) study of intravenous aflibercept (VEGF Trap) plus irinotecan, 5-fluorouracil, and leucovorin (I-LV5FU2) in patients with advanced solid tumors (STs)

O. Rixe, Chris Verslype, D. Khayat et al. · Journal of Clinical Oncology · 2008 · 16 citations

Medicine, Oncology, Pharmacology +17

4509 POSTER Sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC): updated efficacy and safety results and further analysis of prognostic factors

Robert J. Motzer, M. Dror Michaelson, Thomas E. Hutson et al. · European Journal of Cancer Supplements · 2007 · 15 citations

Medicine, Oncology, Cancer Pharmacology +13

Safety and pharmacokinetics of intravenous VEGF Trap plus irinotecan, 5-fluorouracil, and leucovorin (I-LV5FU2) in a combination phase I clinical trial of patients with advanced solid tumors

O. Rixe, Chris Verslype, J. B. Méric et al. · Journal of Clinical Oncology · 2006 · 15 citations

Medicine, Oncology, Pharmacology +8